Kyverna Therapeutics listed its stock on Nasdaq under the ticker KYTX, and Warner Biddle was appointed as the company's CEO.
2 reports, 1 independent
Updated Aug 26
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kyverna Therapeutics listed its stock on Nasdaq under the ticker KYTX, and Warner Biddle was appointed as the company's CEO.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
KYTX
CBS/CW television affiliate in Nacogdoches, Texas, United States
Coverage
Newest first; wire copies grouped- GlobeNewswireKyverna Therapeutics to Present at Upcoming Investor Conferences in September EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biophar
- GlobeNewswireKyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) and BLA submiss